Correlation Between Exelixis and Polydex Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Exelixis and Polydex Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Exelixis and Polydex Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Exelixis and Polydex Pharmaceuticals, you can compare the effects of market volatilities on Exelixis and Polydex Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Exelixis with a short position of Polydex Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Exelixis and Polydex Pharmaceuticals.

Diversification Opportunities for Exelixis and Polydex Pharmaceuticals

0.42
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Exelixis and Polydex is 0.42. Overlapping area represents the amount of risk that can be diversified away by holding Exelixis and Polydex Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Polydex Pharmaceuticals and Exelixis is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Exelixis are associated (or correlated) with Polydex Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Polydex Pharmaceuticals has no effect on the direction of Exelixis i.e., Exelixis and Polydex Pharmaceuticals go up and down completely randomly.

Pair Corralation between Exelixis and Polydex Pharmaceuticals

Given the investment horizon of 90 days Exelixis is expected to generate 0.99 times more return on investment than Polydex Pharmaceuticals. However, Exelixis is 1.01 times less risky than Polydex Pharmaceuticals. It trades about 0.1 of its potential returns per unit of risk. Polydex Pharmaceuticals is currently generating about 0.09 per unit of risk. If you would invest  1,935  in Exelixis on August 31, 2024 and sell it today you would earn a total of  1,711  from holding Exelixis or generate 88.42% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy8.56%
ValuesDaily Returns

Exelixis  vs.  Polydex Pharmaceuticals

 Performance 
       Timeline  
Exelixis 

Risk-Adjusted Performance

18 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Exelixis are ranked lower than 18 (%) of all global equities and portfolios over the last 90 days. Despite quite weak technical and fundamental indicators, Exelixis disclosed solid returns over the last few months and may actually be approaching a breakup point.
Polydex Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Polydex Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Polydex Pharmaceuticals is not utilizing all of its potentials. The recent stock price disturbance, may contribute to mid-run losses for the stockholders.

Exelixis and Polydex Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Exelixis and Polydex Pharmaceuticals

The main advantage of trading using opposite Exelixis and Polydex Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Exelixis position performs unexpectedly, Polydex Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Polydex Pharmaceuticals will offset losses from the drop in Polydex Pharmaceuticals' long position.
The idea behind Exelixis and Polydex Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Other Complementary Tools

Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments